+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Live Attenuated Vaccine"

From
Typhoid Fever Vaccine Market in Japan - Product Thumbnail Image

Typhoid Fever Vaccine Market in Japan

  • Report
  • January 2026
  • 150 Pages
  • Japan
From
Typhoid Fever Vaccine Market in India - Product Thumbnail Image

Typhoid Fever Vaccine Market in India

  • Report
  • January 2026
  • 150 Pages
  • India
From
Typhoid Fever Vaccine Market in Germany - Product Thumbnail Image

Typhoid Fever Vaccine Market in Germany

  • Report
  • October 2025
  • 150 Pages
  • Germany
From
Typhoid Fever Vaccine Market in China - Product Thumbnail Image

Typhoid Fever Vaccine Market in China

  • Report
  • September 2025
  • 150 Pages
  • China
From
From
From
From
From
From
From
From
From
Typhoid Fever Vaccine Market in Canada - Product Thumbnail Image

Typhoid Fever Vaccine Market in Canada

  • Report
  • September 2025
  • 150 Pages
  • Canada
From
From
From
From
From
From
From
Loading Indicator

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus. Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines. Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more